
Bellicum Pharmaceuticals BLCM
$ 0.62
-9.72%
Quarterly report 2023-Q3
added 11-14-2023
Country |
![]() |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Richard Fair |
Employees in the company |
107 |
Shares |
30.8 M |
Market Cap[1] |
$ 5.89 M |
EBITDA (LTM) |
$ -28.3 M |
P/E (LTM) |
-0.83 |
P/S (LTM) |
- |
EPS (LTM) |
-0.75 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.